Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Gene expression analysis of messenger RNP complexes.

Penalva LO, Tenenbaum SA, Keene JD.

Methods Mol Biol. 2004;257:125-34.

PMID:
14770002
2.

Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.

Tenenbaum SA, Lager PJ, Carson CC, Keene JD.

Methods. 2002 Feb;26(2):191-8.

PMID:
12054896
3.

Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays.

Tenenbaum SA, Carson CC, Lager PJ, Keene JD.

Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14085-90.

4.

Genome-wide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera.

Tenenbaum SA, Carson CC, Atasoy U, Keene JD.

Gene. 2003 Oct 23;317(1-2):79-87.

PMID:
14604794
5.

Advances in RIP-chip analysis : RNA-binding protein immunoprecipitation-microarray profiling.

Baroni TE, Chittur SV, George AD, Tenenbaum SA.

Methods Mol Biol. 2008;419:93-108. doi: 10.1007/978-1-59745-033-1_6.

PMID:
18369977
6.
7.

Eukaryotic mRNPs may represent posttranscriptional operons.

Keene JD, Tenenbaum SA.

Mol Cell. 2002 Jun;9(6):1161-7.

8.

Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.

Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24.

9.

[The methods of identifying differences in mRNA expression].

Huang W, Fang XD, Zhao WM, Lin QF.

Sheng Wu Gong Cheng Xue Bao. 2002 Jul;18(4):521-4. Review. Chinese.

PMID:
12385257
10.

Identifying mRNAs bound by RNA-binding proteins using affinity purification and differential display.

Rodgers ND, Jiao X, Kiledjian M.

Methods. 2002 Feb;26(2):115-22.

PMID:
12054888
11.
12.

Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA.

Onesto C, Berra E, Grépin R, Pagès G.

J Biol Chem. 2004 Aug 13;279(33):34217-26. Epub 2004 Jun 2.

14.

Identification of target mRNAs of regulatory RNA-binding proteins using mRNP immunopurification and microarrays.

Sanchez M, Galy B, Hentze MW, Muckenthaler MU.

Nat Protoc. 2007;2(8):2033-42.

PMID:
17703216
15.

Uses and pitfalls of microarrays for studying transcriptional regulation.

Rhodius VA, LaRossa RA.

Curr Opin Microbiol. 2003 Apr;6(2):114-9. Review.

PMID:
12732299
16.

The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.

Farber LJ, Kort EJ, Wang P, Chen J, Teh BT.

Mol Carcinog. 2010 Mar;49(3):215-23. doi: 10.1002/mc.20591.

PMID:
19908240
17.

Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing.

Pearson JL, Robinson TJ, Muñoz MJ, Kornblihtt AR, Garcia-Blanco MA.

J Biol Chem. 2008 Mar 21;283(12):7949-61. doi: 10.1074/jbc.M709402200. Epub 2008 Jan 10.

18.

RNA-binding protein immunopurification-microarray (RIP-Chip) analysis to profile localized RNAs.

Galgano A, Gerber AP.

Methods Mol Biol. 2011;714:369-85. doi: 10.1007/978-1-61779-005-8_23.

PMID:
21431753
19.

Efficient 5' cap-dependent RNA purification : use in identifying and studying subsets of RNA.

Bajak EZ, Hagedorn CH.

Methods Mol Biol. 2008;419:147-60. doi: 10.1007/978-1-59745-033-1_10.

PMID:
18369981
20.

Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels.

Czuczman MS, Olejniczak S, Gowda A, Kotowski A, Binder A, Kaur H, Knight J, Starostik P, Deans J, Hernandez-Ilizaliturri FJ.

Clin Cancer Res. 2008 Mar 1;14(5):1561-70. doi: 10.1158/1078-0432.CCR-07-1254.

Items per page

Supplemental Content

Write to the Help Desk